JPH0153646B2 - - Google Patents
Info
- Publication number
- JPH0153646B2 JPH0153646B2 JP21351881A JP21351881A JPH0153646B2 JP H0153646 B2 JPH0153646 B2 JP H0153646B2 JP 21351881 A JP21351881 A JP 21351881A JP 21351881 A JP21351881 A JP 21351881A JP H0153646 B2 JPH0153646 B2 JP H0153646B2
- Authority
- JP
- Japan
- Prior art keywords
- psh
- activity
- hydantoin
- present
- inhibit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001469 hydantoins Chemical class 0.000 claims description 14
- 150000001875 compounds Chemical class 0.000 claims description 13
- 239000004480 active ingredient Substances 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 6
- 229940118148 Aldose reductase inhibitor Drugs 0.000 claims 1
- 239000003288 aldose reductase inhibitor Substances 0.000 claims 1
- MNQZXJOMYWMBOU-UHFFFAOYSA-N glyceraldehyde Chemical compound OCC(O)C=O MNQZXJOMYWMBOU-UHFFFAOYSA-N 0.000 claims 1
- 230000000694 effects Effects 0.000 description 16
- 229940053195 antiepileptics hydantoin derivative Drugs 0.000 description 7
- 239000003112 inhibitor Substances 0.000 description 7
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 241000283690 Bos taurus Species 0.000 description 3
- 208000002249 Diabetes Complications Diseases 0.000 description 3
- 206010012655 Diabetic complications Diseases 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- TYAVGKKQMQCEOW-UHFFFAOYSA-N 1-(benzenesulfonyl)imidazolidine-2,4-dione Chemical compound O=C1NC(=O)CN1S(=O)(=O)C1=CC=CC=C1 TYAVGKKQMQCEOW-UHFFFAOYSA-N 0.000 description 2
- UGWULZWUXSCWPX-UHFFFAOYSA-N 2-sulfanylideneimidazolidin-4-one Chemical class O=C1CNC(=S)N1 UGWULZWUXSCWPX-UHFFFAOYSA-N 0.000 description 2
- 208000002177 Cataract Diseases 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 2
- 229940091173 hydantoin Drugs 0.000 description 2
- 229910017604 nitric acid Inorganic materials 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000005846 sugar alcohols Chemical class 0.000 description 2
- 238000001308 synthesis method Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- WTSZSAHZIMPSDM-UHFFFAOYSA-N 2-(benzenesulfonamido)acetic acid Chemical compound OC(=O)CNS(=O)(=O)C1=CC=CC=C1 WTSZSAHZIMPSDM-UHFFFAOYSA-N 0.000 description 1
- VDKFCCZUCXYILI-UHFFFAOYSA-N 2-[(4-methylphenyl)sulfonylamino]acetic acid Chemical compound CC1=CC=C(S(=O)(=O)NCC(O)=O)C=C1 VDKFCCZUCXYILI-UHFFFAOYSA-N 0.000 description 1
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 1
- 102000016912 Aldehyde Reductase Human genes 0.000 description 1
- 108010053754 Aldehyde reductase Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000017442 Retinal disease Diseases 0.000 description 1
- 206010038923 Retinopathy Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- -1 as necessary Substances 0.000 description 1
- CSKNSYBAZOQPLR-UHFFFAOYSA-N benzenesulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CC=C1 CSKNSYBAZOQPLR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- WJRBRSLFGCUECM-UHFFFAOYSA-N hydantoin Chemical compound O=C1CNC(=O)N1 WJRBRSLFGCUECM-UHFFFAOYSA-N 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 125000005647 linker group Chemical group 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000002997 ophthalmic solution Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- LXANPKRCLVQAOG-NSHDSACASA-N sorbinil Chemical compound C12=CC(F)=CC=C2OCC[C@@]21NC(=O)NC2=O LXANPKRCLVQAOG-NSHDSACASA-N 0.000 description 1
- 229950004311 sorbinil Drugs 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP21351881A JPS58109418A (ja) | 1981-12-23 | 1981-12-23 | アルド−スレダクタ−ゼの阻害剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP21351881A JPS58109418A (ja) | 1981-12-23 | 1981-12-23 | アルド−スレダクタ−ゼの阻害剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS58109418A JPS58109418A (ja) | 1983-06-29 |
| JPH0153646B2 true JPH0153646B2 (enrdf_load_stackoverflow) | 1989-11-15 |
Family
ID=16640509
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP21351881A Granted JPS58109418A (ja) | 1981-12-23 | 1981-12-23 | アルド−スレダクタ−ゼの阻害剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS58109418A (enrdf_load_stackoverflow) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2197568A1 (en) * | 1995-06-30 | 1997-01-23 | Mochida Pharmaceutical Co., Ltd. | Uricosuric agents |
-
1981
- 1981-12-23 JP JP21351881A patent/JPS58109418A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS58109418A (ja) | 1983-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1591490A (en) | 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate | |
| US5100914A (en) | Arylalkoxycoumarins | |
| US4014934A (en) | Substituted 4'-hydroxyphenyl guanidines and methods of using the same | |
| US4732916A (en) | Novel guanidinomethylbenzoic acid derivatives | |
| JPH05508415A (ja) | ４―アルキルイミダゾール誘導体 | |
| JP2764262B2 (ja) | ヒダントイン誘導体及びそれを有効成分とする医薬組成物 | |
| JPH02255652A (ja) | ベンゼンスルホンアミド類およびその製造方法 | |
| US4663348A (en) | Furosemide salts and pharmaceutical preparations thereof | |
| EP0470006B1 (en) | Thiourea derivatives and antimicrobial agent and antiulcer agent containing the same | |
| DE68911776T2 (de) | Konjugierte Oxybutenolide zur Behandlung von Ulcera. | |
| US4340760A (en) | Monophenylamine derivatives | |
| IL39147A (en) | Amino alcohols derived from ortho trans-hydroxycinnamic acids,their esters and their amides,preparation thereof and pharmaceutical compositions containing them | |
| RU2056416C1 (ru) | Производные тиомочевины, фармацевтическая композиция и способ лечения | |
| US4178386A (en) | Inhibitors of glycolic acid oxidase | |
| JPH0153646B2 (enrdf_load_stackoverflow) | ||
| NL8204062A (nl) | Derivaten van 4-fenyl-4-oxo-2-buteenzuur en zouten daarvan, farmaceutische preparaten op basis daarvan en werkwijze voor het bereiden van een en ander. | |
| EP0134337A1 (en) | Substituted 2,2-dimethyl-5-phenoxypentanoic acid benzamides and their production | |
| JPS6210235B2 (enrdf_load_stackoverflow) | ||
| JPS60158149A (ja) | 炎症抑制作用を有する１，４‐ナフトキノン誘導体 | |
| US4322555A (en) | Nonaprenylamine derivatives | |
| US4755601A (en) | Nonyl prenyl-N heterocyclics | |
| JPH0667880B2 (ja) | ｇｅｍ−ジハロ−１，８−ジアミノ−４−アザ−オクタン類 | |
| SK5512002A3 (en) | Use of 2-imidazolyl substituted carbinols for production of a medicament for treatment or prophylaxis of disease states as a result of ischaemic conditions | |
| KR850000210B1 (ko) | 옥사졸린의 제조방법 | |
| CA1194800A (en) | Antidiabetic compositions |